| Catalog No. | Size | Price (USD) |
| 102306-T08-50 | 50 µL | $147.96 |
| 102306-T08-100 | 100 µL | $251.64 |
| 102306-T08-200 | 200 µL | $355.32 |
General Information
| Product name | Anti-GM130/GOLGA2 Antibody, Rabbit Polyclonal |
| Validated applications | IHC-P (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human GM130/GOLGA2 |
| Immunogen | A synthetic peptide corresponding to the C-terminus of the Human GOLGA2 |
| Preparation | Produced in rabbits immunized with a synthetic peptide corresponding to the C-terminus of the Human GOLGA2, and purified by antigen affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A & Antigen Affinity |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-DEDHMB Antibody; Anti-GM130 Antibody; Anti-golgin-95 Antibody
Image / Experimental Information
| Image 1 Description | Immunochemical staining of human GOLGA2 in human thyroid cancer with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections). |
| Image 1 Alt Text | Human GM130/GOLGA2 Immunohistochemistry(IHC) 15622 |
| Image 1 URL | Source image |
| Image 2 Description | Immunochemical staining of human GOLGA2 in human thyroid cancer with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections). |
| Image 2 Alt Text | Human GM130/GOLGA2 Immunohistochemistry(IHC) 15623 |
| Image 2 URL | Source image |
Background Information
| Description | GOLGA2 knockout mice clearly demonstrated fibrosis features such as autophagy-activated cells, densely packed hepatocytes, increase of alveolar macrophages, and decrease of alveolar surfactant lipids (dipalmitoylphosphatidylcholine). GOLGA2 encodes GM130, a necessary component for the assembly of GA as a single complex, and its deficiency has been found to result in severe cellular phenotypes. The first human patient with a homozygous apparently loss of function mutation in GOLGA2. The phenotype is a neuromuscular disorder characterized by developmental delay, seizures, progressive microcephaly, and muscular dystrophy. |
-HD10MA1439-1ug-thyroid-cancer-IHC-P.png){kind=link}
-HD10MA1439-1ug-liver-IHC-P.png){kind=link}